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Abstract 
Sialoblastoma  is  a  rare  salivary  neoplasm
which  presents  either  congenitally  or  during
early  infancy.  It  was  originally  considered  a
benign neoplasm, however a number of reported
cases have documented locoregional recurrence
and distant metastases. Currently, there is no
consensus on the appropriate treatment for this
neoplasm. We report on long term follow-up of a
patient  with  metastatic  sialoblastoma,  and  a
brief  discussion  of  the  possible  treatment
modalities currently being considered.
Introduction
The pediatric population, specifically under
15 years of age, accounts for only about 4% of
all patients with salivary gland tumors.1 In a
review of the Salivary Gland Register of the
University of Hamburg, only 2.5% of all epithe-
lial  neoplasia  occurred  in  patients  younger
than 20 years.2 Sialoblastoma is a very rare
salivary  tumor  initially  reported  in  1966  by
Vawter and Tefft under the nosology of embry-
oma. This tumor has also been referred to as
congenital basal cell adenoma, basal cell ade-
noma,  and  basaloid  adenocarcinoma.  It  may
present congenitally or perinatally.3 Most com-
monly, it originates in the parotid but may also
arise in the submandibular gland.4,5
Sialoblastomas  were  initially  classified  as
benign.  However,  increasing  experience,
including  reports  of  distant  metastasis,  has
lead to the reclassification of sialoblastomas as
malignant.6,7 Although the mainstay of treat-
ment is surgical resection with adequate mar-
gins,8 there  are  reported  patients  who  have
received alternative treatments such as neoad-
juvant  chemotherapy,  radiation  therapy,  and
even  brachytherapy.  We  have  previously
reported a young child who presented with a
parotid  sialoblastoma  at  the  age  of  3.5
months.9 This report extends the follow-up on
this patient who is now 17 years old and in
remission  for  7  years.  This  represents  the
longest published follow up for a patient with
metastatic sialoblastoma, and the first report
of prolonged remission.   
Case Report
We  originally  reported  a  patient  with  a
sialoblastoma of the left parotid diagnosed at 3
months of age.9 The tumor was locally invasive
and recurred multiple times. Increasing tumor
mitotic  index  and  cytological  pleomorphism
was noted with recurrences (Figure 1). She
was  treated  with  incomplete  surgical  resec-
tion,  chemotherapy  (vincristine,  adriamycin,
cytoxan, etoposide and cisplatinum) and high-
dose  radiation  therapy  at  3.5  years  of  age.
Orbital recurrence developed 1.5 years later,
which was completely resected with negative
margins;  adjuvant  radiation  therapy  was
administered. At 6.5 years of age, she devel-
oped metastasis to the right lung. There was
complete radiologic response after six cycles of
Ifosfamide,  Carboplatinum  and  Etoposide;
however the patient developed metastasis to
the left lung two years later, which responded
to two cycles of Cytoxan and Topotecan (Figure
2).  The  left  lung  metastases  were  resected
with negative margins, and she received six
more courses of adjuvant chemotherapy with
the same agents. Unfortunately 6 months later,
she developed a third pulmonary recurrence in
the right upper lobe, this metastasis was treat-
ed by a wedge resection.  
Presently, this patient is 17 years old; she
remains  in  disease-remission  seven  years
from the last intervention. This remission cer-
tainly seems indicative of a durable response,
as  all  recurrences  had  occurred  at  most  24
months from the end of previous treatment.
Discussion
Primary  surgical  resection  with  negative
margins  is  considered  the  mainstay  therapy
for sialoblastomas.5,8,10,11 In cases complicated
by metastases, recurrences, or difficulties in
surgical  access  or  resectability,  additional
chemotherapy and/or radiation may be neces-
sary.12,13 Neoadjuvant  chemotherapy  and/or
radiation  may  result  in  good  response.
Saribeyoglu et al. reported on a patient with
locally recurrent sialoblastoma who was treat-
ed with chemotherapy only, obviating the need
for surgical intervention.13 Optimistically, that
patient was in remission for 4 years at the time
of  publication.  However,  this  is  an  isolated
report of a durable response; most of the pub-
lished reports lack long term follow-up. Scott et
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Figure 1. Recurrent sialoblastoma, which
forms nests of pleomorphic basaloid cells
with brisk mitotic activity.
Figure 2 Upper panel: low power photomi-
crograph  of  pulmonary  metastasis.  Lower
panel: high power photomicrograph demon-
strating primitive gland formation (G).[page 40] [Rare Tumors 2011; 3:e13]
al. reported a young girl with a sialoblastoma
which had also metastasized to the lungs. The
tumor was resected after a good response to
neo-adjuvant  chemotherapy;  pulmonary
metastases were treated by partial lobectomy.14
Only six months of follow up was reported for
this patient. Ersoz et al. describe a patient still
receiving chemotherapy for pulmonary relapse
at the time of the report.6 Likewise, Prigent et
al. described a patient with sialoblastoma and
pulmonary metastases who was in remission
one year following neoadjuvant chemotherapy
and  resection.12 A  novel  approach  to  tumor
recurrence was recently reported by Shan et al.
In an effort to preserve facial nerve function
and  avoid  a  second  extensive  resection,
brachytherapy with a 125I seed implant was
utilized,  which  lead  to  a  complete  clinical
response after two months. The patient was
disease-free 21 months after this intervention;
however the durability of this response cannot
is unknown.15
In  our  case,  the  increased  tumor  mitotic
index and cytological pleomorphism preceded
development of distant metastases. Despite the
initial response to Ifosfamide, Carboplati  num,
and  Etoposide,  and  Cytoxan  and  Topo  tecan,
chemotherapy and radiation, these modalities
did  not  prevent  ultimate  disease-progression.
Importantly,  surgical  resection  of  pulmonary
metastasis has lead to a durable remission.  
While treatment planning for children with
sialoblastomas  should  be  individualized  for
each patient, surgical resection of recurrent
and  metastatic  disease  provided  our  patient
with a long-term remission.  
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